Abstract:Objective Efferocytosis dysfunction contributes to the progression and rupture of atherosclerotic plaques. Efferocytosis is crucially modulated by intracytoplasmic Ca 2+ , and mitochondrial calcium uniporter (MCU) complex proteins serve as key channels for regulating Ca 2+ concentration. Therefore, it was speculated that MCU may affect the development of atherosclerosis (AS) by regulating efferocytosis. In the present study, we aimed to investigate whether MCU could affect foam cell formation by regulating efferocytosis. Methods We stimulated primary macrophages (Møs) using oxidized low-density lipoprotein (ox-LDL) to mimic the atherosclerotic microenvironment and treated them with Ru360, an MCU-specific inhibitor, and UNC1062, an inhibitor of efferocytosis. Additionally, we conducted double staining to determine the Mø efferocytosis rate. We measured the expression of MCU complexes and efferocytosis-associated proteins using western blotting (WB) and real-time quantitative polymerase chain reaction (RT-qPCR), respectively. In addition, we separately detected the Ca 2+ level in the cytoplasm and mitochondria (MT) using Fluo-4 AM and Rhod-2 methods. We separately determined the reactive oxygen species (ROS) level in cytoplasm and MT using dichlorodihydrofluorescein diacetate (DCFH-DA) fluorescent probing method and Mito-SOXTM superoxide indicator staining. Additionally, we conducted the enzyme-linked immunosorbent assay (ELISA) to detect the production of interleukin-6 (IL-6), interleukin-18 (IL-18), interleukin-1β (IL-1β), and tumor necrosis factor-alpha (TNF-α). Oil Red O staining was performed to measure cytoplasmic lipid levels. Results Ru360 attenuated ox-LDL-induced efferocytosis dysfunction, and attenuated the upregulation of MCU and MCUR1 induced by ox-LDL, and meanwhile attenuated the downregulation of MCUb induced by ox-LDL. Ru360 attenuated the decrease of intracytoplasmic Ca 2+ concentration induced by ox- LDL, Ru360 also attenuated the ROS production induced by ox- LDL, attenuated the release of IL-6, IL-18, IL-1β, and TNF-α induced by ox- LDL, and attenuated the increase of intracytoplasmic lipid content induced by ox-LDL. UNC1062 attenuated the effects of Ru360 in reducing inflammatory cytokines and intracytoplasmic lipid content. Conclusions In this study, we found that MCU inhibition modulated intracytoplasmic Ca 2+ concentration, improved impaired Mø efferocytosis, and reduced ROS generation. Macrophage efferocytosis removed apoptotic cells and prevented the release of inflammatory factor and foam cell formation, and this can be a potential new therapeutic target for alleviating atherosclerosis.

Microrna-181A Represses Ox-Ldl-stimulated Inflammatory Response in Dendritic Cell by Targeting C-Fos

MicroRNA-146a Regulates the Maturation Process and Pro-Inflammatory Cytokine Secretion by Targeting CD40L in Oxldl-Stimulated Dendritic Cells.

MicroRNA-29a Regulates Pro-Inflammatory Cytokine Secretion and Scavenger Receptor Expression by Targeting LPL in Oxldl-Stimulated Dendritic Cells.

Oxidized Low-Density Lipoprotein Upregulates Microrna-146A Via JNK and NF-κB Signaling

ox-LDL increases microRNA-29a transcription through upregulating YY1 and STAT1 in macrophages.

Upregulation of Mirna-155 Expression by OxLDL in Dendritic Cells Involves JAK1/2 Kinase and Transcription Factors YY1 and MYB.

miR-221 Alleviates the Ox-LDL-Induced Macrophage Inflammatory Response via the Inhibition of DNMT3b-Mediated NCoR Promoter Methylation.

Downregulation of TLR4 by Mir-181A Provides Negative Feedback Regulation to Lipopolysaccharide-Induced Inflammation

Microrna-125a-5p Partly Regulates the Inflammatory Response, Lipid Uptake, and Orp9 Expression in Oxldl-Stimulated Monocyte/Macrophages

Expression Profiles of Micrornas in Oxidized Low-Density Lipoprotein-Stimulated RAW 264.7 Cells

Microrna-16 Suppresses The Activation Of Inflammatory Macrophages In Atherosclerosis By Targeting Pdcd4

Oxidized Low-Density Lipoprotein Stimulates Dendritic Cells Maturation Via LOX-1-mediated MAPK/NF-κB Pathway

Retracted Article: LncRNA OIP5-AS1 Contributes to Ox-Ldl-induced Inflammation and Oxidative Stress Through Regulating the Mir-128-3p/cdkn2a Axis in Macrophages

MicroRNA‐181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP‐1 macrophages stimulated by ox‐LDL

DC-SIGN and Toll-like receptor 4 mediate oxidized low-density lipoprotein-induced inflammatory responses in macrophages

Silencing of MEG3 inhibited ox‐LDL‐induced inflammation and apoptosis in macrophages via modulation of the MEG3/miR‐204/CDKN2A regulatory axis

Modulation of Oxidized Low-density Lipoprotein-Affected Macrophage Efferocytosis by Mitochondrial Calcium Uniporter in a Murine Model

MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4.

miR-185-5p Regulates Inflammation and Phagocytosis through CDC42/JNK Pathway in Macrophages

Mir-181a Regulates Inflammation Responses In Monocytes And Macrophages

miR-221-3p inhibits oxidized low-density lipoprotein induced oxidative stress and apoptosis via targeting a disintegrin and metalloprotease-22.